In 2025, Dr Reddy's Laboratories completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Dr Reddy's Laboratories has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Dr Reddy's Laboratories’s data sources below and access millions more through our Disclosure Search.
In 2025, the total operational greenhouse gas (GHG) emissions of Dr Reddy's Laboratories amounted to 339,081 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Dr Reddy's Laboratories increased by 11.47%, suggesting that the company faced challenges in reducing its emissions from its core operations. a b
In 2025, the total Scope 1 emissions of Dr Reddy's Laboratories were 142,772 metric tons of CO₂ equivalent (tCO₂e). a
Since 2021, Dr Reddy's Laboratories's Scope 1 emissions have decreased by 59.2%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2024), Dr Reddy's Laboratories's Scope 1 emissions decreased by 24.67%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
In 2025, Dr Reddy's Laboratories reported Scope 2 greenhouse gas (GHG) emissions of 94,690 tCO₂e using the market-based method and 196,309 tCO₂e using the location-based method. a
Since 2021, Dr Reddy's Laboratories's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have increased by 10.62%, reflecting a rising long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2024), Dr Reddy's Laboratories's Scope 2 emissions (Location-Based) rose by 71.22% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a b
In 2025, Dr Reddy's Laboratories reported its Scope 2 emissions using the market-based method and using the location-based method. a
In 2025, Dr Reddy's Laboratories reported 845,849 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2025 disclosure of Dr Reddy's Laboratories includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, down from 10 in 2024, indicating a decline in reporting granularity and reduced insight into the company's full value chain emissions. a
In 2025, Dr Reddy's Laboratories reported total Scope 3 emissions of 845,849 metric tons of CO₂ equivalent (tCO₂e). a
Since 2021, Dr Reddy's Laboratories's Scope 3 emissions have increased by 79.37%, reflecting a rising long-term trend in Scope 3 emissions over time. a c
Compared to the previous year (2024), Dr Reddy's Laboratories's Scope 3 emissions remained relatively stable, indicating that Dr Reddy's Laboratories 's emissions have plateaued with no significant change in its value chain footprint. a
In 2025, Dr Reddy's Laboratories reported Scope 1 greenhouse gas (GHG) emissions of 142,772 tCO₂e and total revenues of USD 3,810 millions. This translates into an emissions intensity of 37.47 tCO₂e per millions USD. a
In 2025, Dr Reddy's Laboratories reported a Scope 1 emissions intensity of 37.47 tCO₂e per millions USD. Compared to the peer group median of 24.05 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
In 2025, Dr Reddy's Laboratories ranked 15 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Dr Reddy's Laboratories is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
In 2025, Dr Reddy's Laboratories reported a total carbon footprint of 1,184,930 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 1.17% increase compared to 2024, suggesting a rise in emissions across its operations or value chain. a b
The largest contributor to Dr Reddy's Laboratories's total carbon footprint was Scope 3 emissions, accounting for 71.38% of the company's total carbon footprint, followed by Scope 2 emissions at 16.57%. a